These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells. Paju A; Hotakainen K; Cao Y; Laurila T; Gadaleanu V; Hemminki A; Stenman UH; Bjartell A Eur Urol; 2007 Dec; 52(6):1670-9. PubMed ID: 17306443 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland. Bjartell A; Johansson R; Björk T; Gadaleanu V; Lundwall A; Lilja H; Kjeldsen L; Udby L Prostate; 2006 May; 66(6):591-603. PubMed ID: 16388501 [TBL] [Abstract][Full Text] [Related]
5. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival. Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536 [TBL] [Abstract][Full Text] [Related]
6. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252 [TBL] [Abstract][Full Text] [Related]
7. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
8. Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis. Narita S; Tsuchiya N; Saito M; Inoue T; Kumazawa T; Yuasa T; Nakamura A; Habuchi T Prostate; 2008 Feb; 68(3):321-35. PubMed ID: 18175332 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 in patients with prostate cancer. Takeshi U; Sadar MD; Suzuki H; Akakura K; Sakamoto S; Shimbo M; Suyama T; Imamoto T; Komiya A; Yukio N; Ichikawa T Anticancer Res; 2005; 25(6C):4595-8. PubMed ID: 16334148 [TBL] [Abstract][Full Text] [Related]
10. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
11. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
13. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551 [TBL] [Abstract][Full Text] [Related]
14. The expression of a variant prostate-specific antigen in human prostate. Meng FJ; Shan A; Jin L; Young CY Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):305-9. PubMed ID: 11895882 [TBL] [Abstract][Full Text] [Related]
15. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression. Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728 [TBL] [Abstract][Full Text] [Related]
16. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661 [TBL] [Abstract][Full Text] [Related]
17. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2. Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764 [TBL] [Abstract][Full Text] [Related]
19. Rap2 regulates androgen sensitivity in human prostate cancer cells. Bigler D; Gioeli D; Conaway MR; Weber MJ; Theodorescu D Prostate; 2007 Oct; 67(14):1590-9. PubMed ID: 17918750 [TBL] [Abstract][Full Text] [Related]
20. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]